Buy Mircette

Mircette

What is Mircette?

Mircette is a prescription combined oral contraceptive (COC) that contains two active ingredients: desogestrel 0.15 mg (a progestin) and ethinyl estradiol 0.02 mg (a synthetic estrogen). The medication is supplied as a pill and is approved for use in the Hong Kong market under the oversight of the Hong Kong Department of Health. It is indicated for the prevention of pregnancy in women of reproductive age and is marketed by several pharmaceutical companies in tablet form.

How Mircette Works in the Body

Mircette’s two hormonal components act together to prevent pregnancy:

• Ethinyl estradiol provides estrogenic activity that stabilises the endometrium and contributes to the suppression of the hypothalamic-pituitary-ovarian axis.
• Desogestrel is a third-generation progestin that primarily inhibits the mid-cycle surge of luteinising hormone (LH), thereby preventing ovulation. It also thickens cervical mucus, making it more difficult for sperm to penetrate, and alters the uterine lining to reduce the likelihood of implantation.

The combined effect results in no ovulation, reduced sperm motility, and an inhospitable uterine environment, providing highly effective contraception when taken correctly. Onset of contraceptive effect occurs after the first active pill if started within the first five days of menstrual bleeding; otherwise, a backup method is recommended for the first seven days.

Conditions Treated by Mircette

• Primary indication: Prevention of pregnancy in healthy women of childbearing potential.
• Secondary considerations (off-label, see Section 4): None with strong regulatory endorsement in Hong Kong.

Mircette is not indicated for treatment of hormonal disorders such as polycystic ovary syndrome, acne, or menstrual-cycle regulation unless prescribed for those purposes by a qualified clinician.

Patient Suitability and Contraindications

Who Should Use Mircette?

• Women ≥ 15 years old who are seeking reliable, reversible contraception.
• Non-smokers or light smokers (< 15 cigarettes/day) under 35 years of age.
• Individuals with a regular menstrual cycle and no contraindicated medical conditions.

Absolute Contra-indications

• Pregnant or suspected pregnancy.
• History of deep-vein thrombosis (DVT), pulmonary embolism, or other thromboembolic disorders.
• Known or suspected estrogen-dependent malignancy (e.g., breast cancer, endometrial cancer).
• Active liver disease (including hepatic adenoma or severe cirrhosis).
• Uncontrolled hypertension (≥ 160/100 mm Hg).
• Known hypersensitivity to desogestrel, ethinyl estradiol, or any excipients in the tablet.

Relative Contra-indications

• Smoking ≥ 15 cigarettes/day and age ≥ 35 years.
• Migraine headaches with aura.
• Diabetes with vascular complications.
• History of gallbladder disease.
• Use of certain enzyme-inducing drugs (see Interaction section).

Special Populations

• Pregnancy & lactation: Contra-indicated during pregnancy. Breast-feeding women may use Mircette after consulting a healthcare professional, as the low estrogen dose is generally compatible with lactation.
• Elderly: Not typically prescribed; age-related comorbidities often trigger contraindications.
• Renal or hepatic impairment: No routine dose adjustment, but severe liver disease is an absolute contraindication.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Nausea or mild gastrointestinal upset - usually transient.
• Breast tenderness - often improves after the first cycle.
• Headache - can be mitigated by taking the pill with food and adequate hydration.
• Spotting or breakthrough bleeding - most common during the first 2-3 months.
• Mood changes - mild mood swings reported in some users.

Serious Adverse Events

• Venous thromboembolism (VTE) - risk is higher than in non-hormonal users but remains low in healthy, non-smoking women under 35.
• Arterial thrombosis (stroke, myocardial infarction) - more likely in smokers ≥ 35 years or women with uncontrolled hypertension.
• Hepatic adenoma - rare, associated with long-term high-dose estrogen exposure.
• Allergic reactions - rash, urticaria, or angioedema; discontinue immediately and seek medical attention.

If any sign of chest pain, shortness of breath, sudden severe headache, vision changes, or leg swelling develops, seek emergency care.

Drug Interactions

• Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin, griseofulvin, St. John’s wort) can reduce plasma concentrations of both hormones, potentially decreasing contraceptive efficacy.
• Antifungal agents such as ketoconazole may increase estrogen levels, raising the risk of estrogen-related side effects.
• Antiretrovirals (e.g., protease inhibitors) may have variable effects; consultation with a pharmacist is advised.
• Other hormonal products (e.g., additional estrogen therapy, hormonal IUDs) may lead to excess estrogen exposure.

Clinical tip: Inform your prescriber of all prescription medicines, over-the-counter drugs, herbal supplements, and vitamins before starting Mircette.

Food and Lifestyle Interactions

• No major food restrictions; however, consistent daily timing (preferably the same hour each day) maximises efficacy.
• Moderate alcohol consumption does not impair contraceptive action but may increase nausea.
• Driving or operating machinery: No impairment expected, but if dizziness or severe headache occurs, avoid hazardous activities.

How to Take Mircette

• Standard regimen: One tablet daily for 21 consecutive days, followed by a 7-day pill-free interval (or placebo tablets, if supplied).
• Dosage strength: Each active tablet contains desogestrel 0.15 mg and ethinyl estradiol 0.02 mg.
• Timing: Take the pill at the same time each day, preferably with water. Swallow whole; do not split, crush, or chew.
• Missed dose:
• If ≤ 24 hours have passed, take the missed tablet immediately and continue with the next tablet at the usual time (two tablets may be taken on the same day).
• If > 24 hours have passed, start a new pack after taking the missed tablet and use a backup method (e.g., condoms) for the next 7 days.

Special Population Adjustments

• No routine dose adjustments for renal or hepatic impairment, but severe liver disease is a contraindication.
• For women over 35 who smoke, alternative non-hormonal contraception should be discussed.

Overdose

• Symptoms: Nausea, vomiting, abdominal pain, dizziness, and in rare cases, severe hypotension.
• Management: Seek immediate medical attention; supportive care is the mainstay. No specific antidote exists.

Discontinuation

• Stopping Mircette does not require tapering.
• Fertility typically returns within 1 month; however, a withdrawal bleed may not occur if the pill is stopped abruptly.
• If switching to another hormonal method, follow the new product’s initiation guidelines to maintain contraceptive coverage.

Monitoring and Follow-Up

• Baseline evaluation: Blood pressure measurement, medical history review, and assessment for contraindications before the first prescription.
• Ongoing checks: Annual blood pressure check and periodic review of any new risk factors (e.g., smoking status, migraine evolution).
• When to contact a provider: Unexplained leg swelling, severe headaches, chest pain, visual disturbances, persistent heavy bleeding, or any signs of allergic reaction.

Storage and Handling

• Store tablets at ≤ 25 °C (77 °F), protected from light, moisture, and extreme heat.
• Keep the container tightly closed and out of reach of children.
• Do not use tablets beyond the expiration date printed on the package.
• If tablets become compromised (e.g., broken, discolored), discard them according to local pharmacy guidelines and obtain a new supply.

Medication-Specific Glossary

Combined Oral Contraceptive (COC)

A pill that contains both an estrogen and a progestin to provide reversible contraception.

Desogestrel

A third-generation progestin that primarily suppresses ovulation by inhibiting the luteinising hormone surge.

Ethinyl Estradiol

A synthetic estrogen used in low doses to stabilise the endometrium and support contraceptive efficacy.

Thromboembolism

Formation of a blood clot that can travel through the bloodstream and obstruct vessels, a rare but serious risk with estrogen-containing contraceptives.

Medical Disclaimer

This article provides educational information about Mircette and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.